Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

MarketDNA Alert on ALGN

|Includes: Align Technology, Inc. (ALGN)


MarketDNA Update Alert

Buy: Equity – ALGN – Align Tech Inc., - $16.92.
Buy: Derivatives – CUABW, CUABD - Feb 17.5 & Feb 20 Calls
Equity Target: $20.50
Potential Event: Unknown inefficiency in dissemination of information.
Risks: Medium.

Investors,

     Yesterday we notified everyone of an impending move up for ALGN based on trading we were picking up.  After hours today, ALGN announced earnings that exceeded everyone’s expectations and ALGN is trading at $18.50 after hours.  The conference call is occurring now and we will listen in on it.  We believe ALGN will trade tomorrow in the pre-market in the range we are seeing now, $18.50 range and then open up higher in the first 30 minutes.  We still see indications of a move up to $20 but we will see what comes out of the conference call and what upgrades we get tomorrow.

 

Congratulations to all as we should see a 10%+ move at the open tomorrow on the equity and well north of 100% on the Feb 17.50 calls as well as the Feb 20 Calls.

 

As always we will also continue to monitor ALGN and bring you timely actionable trading alerts based on our proprietary investment program.

 

Good Luck Investing.

 

MarketDNA is a unique and very accurate proprietary research channel. MarketDNA uncovers trading which is occurring based on inefficiencies in dissemination of information, typically within fourteen days prior to an event occurring on the equity. MarketDNA provides our clients with actionable opportunity based intelligence and a suite of ala carte custom research solutions, all with exceptional track records and value.

 

IMPORTANT DISCLOSURES 
The distribution of this information has been made to a select group of which every effort has been made to disseminate the information to everyone at the same time. The information contained herein, including any expression of opinion, has been obtained from, or is based upon, sources believed by us to be reliable, but is not guaranteed as to accuracy or completeness.  This is not intended to be an offer to buy or sell or a solicitation of the securities, if any, referred to herein. Our firm and/or its officers and employees from time to time have a position in one or more of the securities mentioned herein. SJL Capital LLC does not trade on recommended equities based on
MarketDNA research for 15 minutes after release of the distributed email alert.  The information and opinions in this report were prepared by MarketDNA and obtained from sources believed to be reliable. MarketDNA in no way guarantees the accuracy or completeness of such information. This report has been prepared for informational purposes only and was issued by MarketDNA for distribution to our market professional, institutional investor & individual customers. Nothing in this report constitutes investment, legal, accounting or tax advice or a representation that any investment or strategy is suitable or appropriate to your individual circumstances, nor does this constitute a personal recommendation to you. Opinions expressed are subject to change without notice and past performance is no guarantee of future result.

 

Matthew Rossi


Managing Partner, Chief Research Officer
MarketDNA Investment Newsletter - A product of SJL Capital LLC

http://www.marketdna.com

admin@marketdna.com

 

From: Matthew Rossi (MarketDNA) [mailto:admin@marketdna.com]
Sent: Tuesday, January 26, 2010 9:10 AM
To: 'admin@marketdna.com'
Subject: MarketDNA Reiterate Alert - ALGN

 


MarketDNA Reiterate Alert

Buy: Equity – ALGN – Align Tech Inc., - $16.92.
Buy: Derivatives – CUABW, CUABD - Feb 17.5 & Feb 20 Calls
Equity Target: $20.50
Potential Event: Unknown inefficiency in dissemination of information.
Risks: Medium.

Investors,

     We are trading on ALGN from yesterday and today that is indicating an impending move up in the near term.  ALGN is up 1.3% today and we are reiterating our buy at this level with a move up to 20+ in the next month.

 

As always we will also continue to monitor ALGN and bring you timely actionable trading alerts based on our proprietary investment program.

 

Good Luck Investing.

 

MarketDNA is a unique and very accurate proprietary research channel. MarketDNA uncovers trading which is occurring based on inefficiencies in dissemination of information, typically within fourteen days prior to an event occurring on the equity. MarketDNA provides our clients with actionable opportunity based intelligence and a suite of ala carte custom research solutions, all with exceptional track records and value.

 

IMPORTANT DISCLOSURES 
The distribution of this information has been made to a select group of which every effort has been made to disseminate the information to everyone at the same time. The information contained herein, including any expression of opinion, has been obtained from, or is based upon, sources believed by us to be reliable, but is not guaranteed as to accuracy or completeness.  This is not intended to be an offer to buy or sell or a solicitation of the securities, if any, referred to herein. Our firm and/or its officers and employees from time to time have a position in one or more of the securities mentioned herein. SJL Capital LLC does not trade on recommended equities based on
MarketDNA research for 15 minutes after release of the distributed email alert.  The information and opinions in this report were prepared by MarketDNA and obtained from sources believed to be reliable. MarketDNA in no way guarantees the accuracy or completeness of such information. This report has been prepared for informational purposes only and was issued by MarketDNA for distribution to our market professional, institutional investor & individual customers. Nothing in this report constitutes investment, legal, accounting or tax advice or a representation that any investment or strategy is suitable or appropriate to your individual circumstances, nor does this constitute a personal recommendation to you. Opinions expressed are subject to change without notice and past performance is no guarantee of future result.

 

Matthew Rossi



Managing Partner, Chief Research Officer
MarketDNA Investment Newsletter - A product of SJL Capital LLC

http://www.marketdna.com

admin@marketdna.com

 

 

 

 

From: Matthew Rossi (MarketDNA) [mailto:admin@marketdna.com]
Sent: Thursday, January 21, 2010 12:41 PM
To: 'admin@marketdna.com'
Subject: MarketDNA Alert - ALGN

 


MarketDNA Research Alert

Buy: Equity – ALGN – Align Tech Inc., - $16.92.
Buy: Derivatives – CUABW, CUABD - Feb 17.5 & Feb 20 Calls
Equity Target: $20.50
Potential Event: Unknown inefficiency in dissemination of information.
Risks: Medium.

Investors,

     We are seeing multiple indications of a potential downward movement for ALGN, Align Technology Incorporated from our proprietary investment program and believe ALGN will move up to $20.00+ within the next month.  The call options chart below shows the volume that increased over the last two trading days.  The option volume is now moved to Open Interest, while the equity itself & the volume has remained flat over the same time span.

 

                   

    Align Technology, Inc. designs, manufactures, and markets the invisalign system for treating malocclusion or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. The company’s products include Invisalign Full for the treatment of a range of malocclusions; Invisalign Express, a solution for less complex orthodontic cases; Invisalign Teen, which is designed to meet the specific needs of the non-adult comprehensive or teen treatment market; Vivera retainers that offer aesthetic retention solution for invisalign and non-invisalign patients; and Invisalign Assist, which is designed for general practitioners for selecting, monitoring, and finishing invisalign cases. It also offers ancillary products comprising cleaning material and adjusting tools for dental professionals. Align Technology, Inc. distributes its products directly to orthodontists and general practitioner dentists in North America, Europe, the Asia Pacific, Latin America, and Japan. The company was founded in 1997 and is headquartered in Santa Clara, California.


     Currently trading at about $16.92, we believe, based on our proprietary program, an upward movement to $20.00+ within the next month is forthcoming. ALGN trades on average 500,000 shares per day, and has traded up from $16 back in November.

 

We recommend shorting the equity straight out between $16.80 and $17.150, If you like derivatives, we recommend the February 17.5 Calls. If you want to take additional risk/reward the February 20 Calls are also recommended.


ADDITIONAL METRICS:


RELATED COMPANIES:

Ticker

Company name

Exchange

Price

Change

Chg %

Earnings per share

P/E ratio

Mkt Cap

 

ALGN

Align Technology, Inc.

NASDAQ

16.94

-0.74

-4.19%

0.37

45.90

1.26B

 

YDNT

Young Innovations, Inc.

NASDAQ

23.31

-1.18

-4.82%

1.65

14.12

184.49M

 

XRAY

DENTSPLY Intl. Inc.

NASDAQ

34.79

-1.34

-3.71%

1.80

19.32

5.17B

 

NADX

National Dentex Corp.

NASDAQ

8.27

-0.04

-0.42%

0.01

830.82

47.70M

 

BLTI

Biolase Technology, Inc.

NASDAQ

1.94

-0.06

-3.00%

-0.28

 

47.22M

 

SIRO

Sirona Dental Systems,...

NASDAQ

32.92

-0.81

-2.40%

0.96

34.42

1.81B

 

BSML

BSML, Inc.

OTC

0.0220

0.0000

0.00%

-0.15

 

316,823.00

 

MLSS

Milestone Scientific Inc.

OTC

1.55

0.00

0.00%

-0.12

 

21.61M

 

LANZ

Lancer Orthodontics, Inc.

OTC

0.150

0.000

0.00%

0.04

3.69

422,979.00

 

BMRA

Biomerica, Inc.

OTC

0.370

-0.015

-3.90%

0.03

12.09

2.45M

 

 

                   

 

                   
                               

 

FINANCIALS:

Revenue

79.27

76.32

Other Revenue, Total

-

-

Total Revenue

79.27

76.32

Cost of Revenue, Total

20.27

18.34

Gross Profit

59.00

57.98

Selling/General/Admin. Expenses, Total

43.91

45.65

Research & Development

5.61

5.67

Depreciation/Amortization

-

-

Interest Expense(Income) - Net Operating

-

-

Unusual Expense (Income)

69.67

0.41

Other Operating Expenses, Total

-

-

Total Operating Expense

139.46

70.06

Operating Income

-60.19

6.25

Interest Income(Expense), Net Non-Operating

-

-

Gain (Loss) on Sale of Assets

-

-

Other, Net

-0.37

0.36

Income Before Tax

-60.47

6.81

Income After Tax

-49.94

4.54

Minority Interest

-

-

Equity In Affiliates

-

-

Net Income Before Extra. Items

-49.94

4.54

Accounting Change

-

-

Discontinued Operations

-

-

Extraordinary Item

-

-

Net Income

-49.94

4.54

Revenue

79.27

76.32

 

Good Luck Investing.

 

Visit us at http://www.MarketDNA.com & register for FREE

 

 

MarketDNA is a unique and very accurate proprietary research channel. MarketDNA uncovers trading which is occurring based on inefficiencies in dissemination of information, typically within fourteen days prior to an event occurring on the equity. MarketDNA provides our clients with actionable opportunity based intelligence and a suite of ala carte custom research solutions, all with exceptional track records and value.

 

IMPORTANT DISCLOSURES 
The distribution of this information has been made to a select group of which every effort has been made to disseminate the information to everyone at the same time. The information contained herein, including any expression of opinion, has been obtained from, or is based upon, sources believed by us to be reliable, but is not guaranteed as to accuracy or completeness.  This is not intended to be an offer to buy or sell or a solicitation of the securities, if any, referred to herein. Our firm and/or its officers and employees from time to time have a position in one or more of the securities mentioned herein. SJL Capital LLC does not trade on recommended equities based on
MarketDNA research for 15 minutes after release of the distributed email alert.  The information and opinions in this report were prepared by MarketDNA and obtained from sources believed to be reliable. MarketDNA in no way guarantees the accuracy or completeness of such information. This report has been prepared for informational purposes only and was issued by MarketDNA for distribution to our market professional, institutional investor & individual customers. Nothing in this report constitutes investment, legal, accounting or tax advice or a representation that any investment or strategy is suitable or appropriate to your individual circumstances, nor does this constitute a personal recommendation to you. Opinions expressed are subject to change without notice and past performance is no guarantee of future result.

 

Matthew Rossi

Managing Partner, Chief Research Officer
MarketDNA Investment Newsletter - A product of SJL Capital LLC

admin@marketdna.com

 

http://www.marketdna.com

 



Disclosure: We obtained a position in this stock after our first alert